Acute myeloid leukemia: How the uninsured fare

Cancer

Volumn 117, Issue 20, 2011, Pages 4772-4778

  Bradley, Cathy J ^a   Dahman, Bassam ^a   Jin, Yan ^a   Shickle, Lisa M ^a   Ginder, Gordon D ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

acute myeloid leukemia; and survival; costs; disparities; health insurance; race

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AFRICAN AMERICANS; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CONFOUNDING FACTORS (EPIDEMIOLOGY); ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HOSPITAL COSTS; HUMANS; INPATIENTS; INSURANCE, HEALTH; LENGTH OF STAY; LEUKEMIA, MYELOID, ACUTE; LOGISTIC MODELS; MALE; MEDICAID; MEDICALLY UNINSURED; MEDICARE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETREATMENT; UNITED STATES; VIRGINIA;

EID: 80053925171     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26095     Document Type: Article

References (23)

1. American Cancer Society. Cancer facts and figures 2010. Available at: Accessed March 11, 2009.
2. Menzin J, Lang K, Earle CC, et al. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med. 2002; 162: 1597-1603. (Pubitemid 34773427)
3. Fey M, Dreyling M, ESMO Guidelines Working Group. Acute myeloblastic leukemia in adult patients: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009; 20 (suppl 4): 100-101.
4. Kantarjian H, Ravandi F, O'Brien S, et al. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia. Blood. 2010; 116: 4422-4429.
5. Burnett A, Wetzler M, Lowenberg B,. Therapeutic advances in acute myeloid leukemia [published online ahead of print January 10, 2011]. J Clin Oncol. doi: 10.1200/JCO.2010.30.1820.
6. Virnig BA, Baxter NN, Habermann EB, et al. A matter of race: early-versus late-stage cancer diagnosis. Health Aff. 2009; 28: 160-168.
7. Laiyemo AO, Doubeni C, Pinsky PF, et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst. 2010; 102: 538-546.
8. Jayadevappa R, Malkowicz SB, Chhatre S, et al. Racial and ethnic variation in health resource use and cost for prostate cancer. BJU Int. 2010; 106: 801-808.
9. Riall TS, Townsend CM Jr, Kuo YF, et al. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer. 2010; 116: 930-939.
10. Hollenbeck BK, Dunn RL, Ye Z, et al. Racial disparities in treatment and outcomes among patients with early stage bladder cancer. Cancer. 2010; 116: 50-56.
11. Doubeni CA, Field TS, Buist DS, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007; 109: 612-620. (Pubitemid 46190971)
12. Halpern MT, Ward EM, Pavluck AL, et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9: 222-231.
13. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008; 58: 9-31.
14. SEER-Medicare Linked Database. National Cancer Institute Health Services and Economics. Available at: Accessed September 27, 2010.
15. Cashen AF, Schiller GJ, O'Donnell MR, DiPersio JF,. Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. J Clin Oncol. 2010; 28: 556-561.
16. Fenaux P, Bowen D, Gattermann N, et al. Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion. Leuk Res. 2010; 34: 1410-1416.
17. Bureau of Labor Statistics. Consumer price index. Available at:. Accessed March 11, 2009.
18. Kristinsson SY, Derolf AR, Edgren G, et al. Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in Sweden. J Clin Oncol. 2009; 27: 2073-2080.
19. Bhayat F, Das-Gupta E, Smith C, et al. The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer. 2009; 9: 252.
20. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001; 345: 99-106. (Pubitemid 32634569)
21. Birkmeyer NJ, Gu N, Baser O, et al. Socioeconomic status and surgical mortality in the elderly. Med Care. 2008; 46: 893-899.
22. Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006; 107: 3481-3485.
23. Katz LM, Howell JB, Doyle JJ, et al. Outcomes and charges of elderly patients with acute myeloid leukemia. Am J Hematol. 2006; 81: 850-857. (Pubitemid 44682187)